乳腺钼靶X线摄影联合彩色多普勒超声诊断T1期乳腺癌的价值

打开文本图片集

【摘 要】目的：对T1期乳腺癌患者联合应用乳腺钼靶及彩色多普勒超声诊断，并分析其诊断价值。方法：选取2019年2月至2021年10月，在我院治疗的42例T1 期乳腺癌患者，所有患者均应用乳腺 X 线钼靶检查及彩色多普勒超声检查，比较两者单独诊断及联合诊断的符合率。结果：乳腺 X 线钼靶诊断T1 期乳腺癌的阳性符合率为64.29%，彩色多普勒超声诊断阳性符合率为59.52%，联合诊断阳性符合率为83.33%，联合诊断阳性符合率明显高于两者单独诊断（P

【关键词】乳腺癌；彩色多普勒超声；乳腺钼靶

Value of breast molybdenum target combined with color Doppler ultrasound in the diagnosis of stage T1 breast cancer

FAN Weizhong

Yangzhou City Jiangdu Maternal and Child Health Care Hospital， Yangzhou， Jiangsu 225200， China

【Abstract】Objective： To combine breast molybdenum target and color Doppler ultrasound in patients with stage T1 breast cancer and analyze its diagnostic value.Methods： 42 patients with stage T1 breast cancer treated in our hospital from February 2019 to October 2021 used breast X-ray molybdenum target examination and color Doppler ultrasound to compare the compliance rate of separate diagnosis and combined diagnosis.Results： The positive compliance rate of T1 breast cancer was 64.29%， color Doppler ultrasound was 59.52%， and 83.33%. The positive compliance rate was significantly higher than that separately（P

【Key？Words】Breast cancer； Color Doppler ultrasound； Breast molybdenum target

乳腺癌是威胁成年女性生命健康的常见恶性肿瘤，自20世纪 90 年代以来，我国乳腺癌发病率、死亡率均明显升高，据相关数据显示，预计2030 年乳腺癌患病人数可达到23.4 万例，与2008 年相比，其增长率可达到31.15%。（剩余3054字）